← Leaderboards
Yun Qiu
University Of Minnesota Twin Cities
$5,397,385
Attributed
$5,397,385
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $607.9K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,397,385 · 3
VA$0 · 1
By mechanism
R01$5,397,385 · 3
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Paul C Marker$5,910,239
- Margaret Elizabeth Ross$38,646,431
- Lara S Collier$3,550,994
- Lihsia Chen$3,872,524
- Michael J. Wilson$705,783
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstatePlayCastrationInsightGrowthOverexpressionSignal PathwaySignal TransductionRegulationProstateLeadMediatingAndrogen ReceptorAblationMouse ModelAndrogensMolecularPhosphotransferasesEffective TherapyResistanceProstate Cancer TherapyProteinsPhospho-Specific AntibodiesGrowth Factor
Grant awards (33)
Mechanisms of Therapeutic Resistance in Prostate Cancer$0
I01 · FY2022 · VA · contact PI
Mechanisms of Therapeutic Resistance in Prostate Cancer$0
I01 · FY2021 · VA · contact PI
Mechanisms of Therapeutic Resistance in Prostate Cancer$0
I01 · FY2020 · VA · contact PI
Mechanisms of Therapeutic Resistance in Prostate Cancer$0
I01 · FY2019 · VA · contact PI
Mechanisms of Therapeutic Resistance in Prostate Cancer$0
I01 · FY2018 · VA · contact PI
Role of RNF6 in survival signaling$318,513
R01 · FY2017 · CA · contact PI
Role of RNF6 in survival signaling$318,513
R01 · FY2016 · CA · contact PI
Role of RNF6 in survival signaling$318,513
R01 · FY2015 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$252,809
R01 · FY2015 · CA · contact PI
Role of RNF6 in survival signaling$308,958
R01 · FY2014 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$245,225
R01 · FY2014 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$23,841
R01 · FY2014 · CA · contact PI
Role of RNF6 in survival signaling$318,513
R01 · FY2013 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$237,641
R01 · FY2013 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$51,755
R01 · FY2013 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$252,809
R01 · FY2012 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$55,058
R01 · FY2012 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$252,809
R01 · FY2011 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$25,249
R01 · FY2011 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$25,005
R01 · FY2010 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$250,280
R01 · FY2009 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$59,064
R01 · FY2009 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$250,280
R01 · FY2008 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$58,349
R01 · FY2008 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$250,280
R01 · FY2007 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$257,756
R01 · FY2006 · CA · contact PI
Molecular Mechanisms of Hormone-independence of Prostate Cancer$263,959
R01 · FY2005 · CA
IL6 &NEUROENDOCRINE DIFFERENTIATION OF PROSTATE CANCER$200,475
R01 · FY2004 · CA
IL6 &NEUROENDOCRINE DIFFERENTIATION OF PROSTATE CANCER$200,475
R01 · FY2003 · CA
IL6 &NEUROENDOCRINE DIFFERENTIATION OF PROSTATE CANCER$199,557
R01 · FY2002 · CA
IL6 &NEUROENDOCRINE DIFFERENTIATION OF PROSTATE CANCER$918
R01 · FY2002 · CA
IL6 &NEUROENDOCRINE DIFFERENTIATION OF PROSTATE CANCER$200,475
R01 · FY2001 · CA
IL6 &NEUROENDOCRINE DIFFERENTIATION OF PROSTATE CANCER$200,306
R01 · FY2000 · CA